Reporting quality of randomized-controlled trials in multiple sclerosis from 2000 to 2015, based on CONSORT statement

Multiple Sclerosis and Related Disorders

Volumn 9, Issue , 2016, Pages 135-139

  Rikos, Dimitrios ^a   Dardiotis, Efthimios ^a   Tsivgoulis, Georgios ^b,c   Zintzaras, Elias ^a,d   Hadjigeorgiou, Georgios M ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CONSORT; Multiple sclerosis; Randomized controlled trials

Indexed keywords

ARTICLE; CHECKLIST; CLINICAL PRACTICE; CLINICAL RESEARCH; CONTROLLED STUDY; COST CONTROL; DATA BASE; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; MULTIPLE SCLEROSIS; PILOT STUDY; POST HOC ANALYSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); VALIDITY; JOURNAL IMPACT FACTOR; PUBLICATION; PUBLISHING; STANDARDS;

HUMANS; JOURNAL IMPACT FACTOR; MULTIPLE SCLEROSIS; PERIODICALS AS TOPIC; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84980371949     PISSN: 22110348     EISSN: 22110356     Source Type: Journal    
DOI: 10.1016/j.msard.2016.07.013     Document Type: Article

References (24)

1. Nystrom, L., Rutqvist, L.E., Wall, S., et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341 (1993), 973–978.
2. Kober, T., Trelle, S., Engert, A., Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals. J. Natl. Cancer Inst. 98 (2006), 620–625.
3. Stolberg, H.O., Norman, G., Trop, I., Randomized controlled trials. Am. J. Roentgenol. 183 (2004), 1539–1544.
4. Pfeifer, M.P., Snodgrass, G.L., The continued use of retracted, invalid scientific literature. J. Am. Med. Assoc. 263 (1990), 1420–1423.
5. Olkin, I., Meta-analysis: reconciling the results of independent studies. Stat. Med. 14 (1995), 457–472.
6. Moher, D., Pham, B., Jones, A., et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 352 (1998), 609–613.
7. Schulz, K.F., Chalmers, I., Hayes, R.J., Altman, D.G., Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. J. Am. Med. Assoc. 273 (1995), 408–412.
8. Begg, C., Cho, M., Eastwood, S., et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. J. Am. Med. Assoc. 276 (1996), 637–639.
9. Mills, E.J., Wu, P., Gagnier, J., Devereaux, P.J., The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemp. Clin. Trials 26 (2005), 480–487.
10. Huwiler-Muntener, K., Juni, P., Junker, C., Egger, M., Quality of reporting of randomized trials as a measure of methodologic quality. J. Am. Med. Assoc. 287 (2002), 2801–2804.
11. Juni, P., Altman, D.G., Egger, M., Systematic reviews in health care: assessing the quality of controlled clinical trials. Br. Med. J. (Clin. Res. Ed.) 323 (2001), 42–46.
12. Liberati, A., Himel, H.N., Chalmers, T.C., A quality assessment of randomized control trials of primary treatment of breast cancer. J. Clin. Oncol. 4 (1986), 942–951.
13. Turner, L., Shamseer, L., Altman, D.G., et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst. Rev., 2012, 11 Mr000030.
14. Schulz, K.F., Altman, D.G., Moher, D., CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med., 8, 2010, 18.
15. Berer, K., Krishnamoorthy, G., Microbial view of central nervous system autoimmunity. FEBS Lett. 588 (2014), 4207–4213.
16. Ziogas, D.C., Zintzaras, E., Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement. Ann. Epidemiol. 19 (2009), 494–500.
17. Lai, T.Y., Wong, V.W., Lam, R.F., Cheng, A.C., Lam, D.S., Leung, G.M., Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals. Ophthalmic Epidemiol. 14 (2007), 390–398.
18. Agha, R., Cooper, D., Muir, G., The reporting quality of randomised controlled trials in surgery: a systematic review. Int. J. Surg. 5 (2007), 413–422.
19. Hill, C.L., Buchbinder, R., Osborne, R., Quality of reporting of randomized clinical trials in abstracts of the 2005 annual meeting of the American College of Rheumatology. J. Rheumatol. 34 (2007), 2476–2480.
20. Farrokhyar, F., Chu, R., Whitlock, R., Thabane, L., A systematic review of the quality of publications reporting coronary artery bypass grafting trials. Can. J. Surg. J. Can. De Chir. 50 (2007), 266–277.
21. Mills, E., Loke, Y.K., Wu, P., et al. Determining the reporting quality of RCTs in clinical pharmacology. Br. J. Clin. Pharmacol. 58 (2004), 61–65.
22. Partsinevelou, A., Zintzaras, E., Quality of reporting of randomized controlled trials in polycystic ovary syndrome. Trials, 10, 2009, 106.
23. Signori, A., Baccino, A., Sormani, M.P., The quality of reports of randomized trials in multiple sclerosis: a review. Mult. Scler. 18 (2012), 776–781.
24. Thomson Reuters, 2016. 2015 Journal Citation Reports®.